期刊
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY
卷 9, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fbioe.2021.820468
关键词
bone remodeling; ROS-responsive biomaterials; bone-related diseases; bone regeneration; photodynamic therapy
资金
- National Key R&D Program of China [2018YFC2001500]
- National Natural Science Foundation of China [91749204, 82172098, 81771491]
- Shanghai Municipal Health Commission General Program [201740237]
Reactive oxygen species (ROS) play a crucial role in the bone microenvironment and excessive accumulation of ROS can lead to bone metabolic diseases. Therefore, ROS-responsive biomaterials are considered promising strategies for treating bone-related diseases.
Reactive oxygen species (ROS) are the key signaling molecules in many physiological signs of progress and are associated with almost all diseases, such as atherosclerosis, aging, and cancer. Bone is a specific connective tissue consisting of cells, fibers, and mineralized extracellular components, and its quality changes with aging and disease. Growing evidence indicated that overproduced ROS accumulation may disrupt cellular homeostasis in the progress of bone modeling and remodeling, leading to bone metabolic disease. Thus, ROS-responsive biomaterials have attracted great interest from many researchers as promising strategies to realize drug release or targeted therapy for bone-related diseases. Herein, we endeavor to introduce the role of ROS in the bone microenvironment, summarize the mechanism and development of ROS-responsive biomaterials, and their completion and potential for future therapy of bone-related diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据